gossypol has been researched along with aurintricarboxylic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adhikari, S; Dakshanamurthy, S; Devito, S; Dixon, M; Gupta, S; Karmahapatra, SK; Roy, R; Vasudevan, S; Woodrick, J; Yenugonda, VM | 1 |
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
Cavalli, A; Myers, SH; Ortega, JA | 1 |
Ahn, HM; Du, Y; Fan, D; Fu, H; Ivanov, AA; Liang, B; Qian, K; Troha, AH; Yang, X | 1 |
1 review(s) available for gossypol and aurintricarboxylic acid
Article | Year |
---|---|
Synthetic Lethality through the Lens of Medicinal Chemistry.
Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases; DNA-Activated Protein Kinase; Genes, BRCA2; Humans; Neoplasms; Poly(ADP-ribose) Polymerases; Precision Medicine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rad51 Recombinase; Synthetic Lethal Mutations | 2020 |
3 other study(ies) available for gossypol and aurintricarboxylic acid
Article | Year |
---|---|
Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease.
Topics: Cell Line, Tumor; DNA Glycosylases; DNA Repair; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship | 2015 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.
Topics: Antineoplastic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Humans; MAP Kinase Kinase 3; Molecular Docking Simulation; Molecular Structure; Neoplasms; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Small Molecule Libraries; Structure-Activity Relationship | 2021 |